Press release
Fecal Calprotectin Test Market Driven by Strategic Collaborations and Expansion of Molecular Diagnostic Technologies
Fecal Calprotectin Test Market
According to the latest research by InsightAce Analytic, the Global Fecal Calprotectin Test Market is valued at US$ 140.2 Mn in 2023, and it is expected to reach US$ 280.5 Mn by 2031, with a CAGR of 9.17% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2659
Fecal calprotectin testing represents a critical non-invasive diagnostic approach for assessing gastrointestinal inflammation. Calprotectin, a protein released by white blood cells during inflammatory responses, serves as a reliable biomarker for identifying underlying gastrointestinal conditions. The global fecal calprotectin testing market is projected to experience substantial growth over the coming years, primarily driven by the increasing prevalence of inflammatory bowel disease (IBD) and other gastrointestinal disorders. These tests are most commonly utilized among adult populations, reflecting the higher incidence rates of IBD and colorectal cancer within this group.
Market expansion is being further propelled by growing awareness among healthcare professionals and patients regarding the value of early detection and timely management of gastrointestinal diseases. The rising adoption of personalized medicine, along with government initiatives promoting colorectal cancer screening, is also contributing to heightened demand for fecal calprotectin testing. Moreover, the introduction of home-based testing kits has enhanced patient accessibility and convenience, supporting greater uptake of routine gastrointestinal health monitoring.
Ongoing technological advancements in diagnostic platforms and the increasing preference for non-invasive testing methodologies are key factors accelerating market growth. Additionally, untapped opportunities in emerging economies and the continued development of at-home testing solutions present significant potential for market expansion. Nonetheless, challenges such as limited public awareness and insufficient insurance reimbursement-particularly in developing regions-remain barriers to widespread adoption and market penetration.
List of Prominent Players in the Fecal Calprotectin Test Market:
• Abbexa
• ALPCO
• Alpha Laboratories
• Biomerica
• BÜHLMANN Laboratories AG
• DRG Instruments GmbH
• EagleBio
• Epitope Diagnostics, Inc.
• OPERON, S.A.
• R-Biopharm AG
• Svar Life Science
• Thermo Fisher Scientific Inc.
• Werfen
• SENTINEL CH. SpA
• Diazyme Laboratories, Inc.
• DiAgam
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Drivers:
The fecal calprotectin testing market is witnessing strong growth, driven by the rising need for early and precise diagnostic solutions alongside continuous advancements in diagnostic technology. As global healthcare systems increasingly emphasize accurate and timely disease detection, the demand for dependable diagnostic tools for gastrointestinal disorders has grown substantially to improve treatment outcomes and patient care.
Technological innovations-such as the introduction of automated analyzers, advanced assay methodologies, and high-sensitivity test kits-have enhanced the accuracy, efficiency, and accessibility of fecal calprotectin testing. These developments have shortened diagnostic turnaround times and strengthened clinical reliability, thereby encouraging broader adoption across hospitals, diagnostic laboratories, and primary care settings worldwide.
Challenges:
Despite its strong growth outlook, the fecal calprotectin testing market faces several operational and economic challenges. High testing costs, particularly in resource-limited healthcare environments, continue to restrict widespread adoption. Additionally, insufficient awareness among healthcare practitioners and patients regarding the clinical significance of fecal calprotectin as a non-invasive biomarker hinders broader utilization.
Regulatory complexities, coupled with stringent quality and validation requirements, pose further challenges for manufacturers seeking market entry and expansion. Moreover, logistical issues related to sample collection, transportation, and processing can affect result accuracy and limit testing reliability, potentially reducing clinical confidence and adoption rates in certain regions.
Regional Trends:
North America is expected to retain a leading position in the global fecal calprotectin testing market, supported by a robust healthcare infrastructure, high awareness of gastrointestinal disorders, and growing adoption of non-invasive diagnostic technologies. The region's strong commitment to early disease detection, combined with substantial investments in research and technological innovation, continues to drive market advancement.
Europe also represents a significant market, underpinned by increasing prevalence of inflammatory bowel disease and colorectal cancer, a strong focus on preventive healthcare, and active government support for diagnostic innovation. The region's expanding patient base, favorable reimbursement landscape, and rising healthcare expenditure further reinforce its prominence in the global market.
Recent Developments:
• In May 2024, ALPCO-GeneProof, a world leader in molecular diagnostics, and Revvity's EUROIMMUN division, a top producer of in-vitro diagnostic products, established a strategic alliance to increase the availability of GeneProof PCR kits across the EU. As a result of this partnership, the cutting-edge molecular diagnostic technologies developed by ALPCO-GeneProof will be combined with EUROIMMUN's vast distribution network and support infrastructure.
• In May 2024, Epitope Diagnostics, Inc. introduced its fully automated chemiluminescent immunoassay devices (ECL25 and ECL100) along with panel kits that include both common and specialized chemiluminescent immunoassay tests for a range of clinical types.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2659
Segmentation of Fecal Calprotectin Test Market-
Fecal Calprotectin Test Market- By Patient Type
• Adult
• Pediatric
Fecal Calprotectin Test Market- By Assay Type
• ELISA (Enzyme-linked Immunosorbent Assay)
• Enzyme Fluoroimmunoassay
• Quantitative Immune-Chromatography
Fecal Calprotectin Test Market- By Indication
• Inflammatory Bowel Disease
• Colorectal Cance
• Celiac Disease
Fecal Calprotectin Test Market- By End-User
• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
Fecal Calprotectin Test Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/fecal-calprotectin-test-market/2659
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fecal Calprotectin Test Market Driven by Strategic Collaborations and Expansion of Molecular Diagnostic Technologies here
News-ID: 4244202 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Synthetic Lethality-based Drugs and Targets Market Driven by Rising Cancer Incid …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Synthetic Lethality-based Drugs and Targets Market - (By Type (Monotherapy, Combination Therapy), By Application (Medical Research Institution, Hospital and Clinic)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Synthetic Lethality-based Drugs and Targets Market is expected grow with a CAGR of 14.5% during the forecast…
Tattoo Needle Market Supported by Technological Innovations in Cartridge Design …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Tattoo Needle Market- (By Type (Temporary, Permanent), By Location (Upper Arm, Chest, Abdomen, Others), By End-user (Men, Women), By Product Type (Magnum, Round Liners, Round Shaders, Cartridge, Others), By Application (Lining, Shading or Colouring), By Needle Size (12 (0.35 mm), 10 (0.30 mm), 8 (0.25 mm), 6(0.20 mm), Others)), By Region, Trends, Industry Competition Analysis,…
Plant Growth Chamber Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plant Growth Chamber Market Size, Share & Trends Analysis Report By Type (Reach-In, Walk-In), By Application (Clinical research, Academic research) , Region, Market Outlook And Industry Analysis 2034"
The global plant growth chamber market is estimated to reach over USD 761.7 million by 2034, exhibiting a CAGR of 5.90% during the forecast period.
Request For Free…
Nanoparticle Formulation Market Report on the Untapped Growth Opportunities in t …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Nanoparticle Formulation Market Size, Share & Trends Analysis Report By Type of Nanoparticle Formulated (Organic Nanoparticles, Inorganic Nanoparticles, Carbon-based Nanoparticles) By Type of Organic Nanoparticle Formulated (Polymeric Nanoparticles, Lipid Nanoparticles, Viral Nanoparticles, Protein-based Nanoparticles, and Other Organic Nanoparticles), By Type of Inorganic Nanoparticle Formulated (Metal Nanoparticles, Quantum Dots, Silica Nanoparticles, Magnetic Nanoparticles, and Other Inorganic Nanoparticles),…
More Releases for Fecal
Emerging Trends Influencing The Growth Of The Fecal Microbiota Transplantation ( …
The Fecal Microbiota Transplantation (FMT) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Fecal Microbiota Transplantation (FMT) Market Size Expected to Be by 2034?
The fecal microbiota transplantation (FMT) market size has grown from $0.85 billion in 2024 to $0.91 billion in…
Evolving Market Drivers In The Fecal Transplant Therapy Industry: Rising Inflamm …
The Fecal Transplant Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Fecal Transplant Therapy Market Size During the Forecast Period?
The fecal transplant therapy market size has grown from $2.02 billion in 2024 to $2.15 billion in 2025, with a CAGR…
Emerging Trends Influencing The Growth Of The Fecal Microbiota Transplantation ( …
The Fecal Microbiota Transplantation (FMT) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Fecal Microbiota Transplantation (FMT) Market Size Expected to Be by 2034?
The fecal microbiota transplantation (FMT) market size has grown from $0.85 billion in 2024 to $0.91 billion in…
Prominent Fecal Microbiota Transplantation (FMT) Market Trend for 2025: Innovati …
How Are the key drivers contributing to the expansion of the fecal microbiota transplantation (fmt) market?
Heightened occurrence rates of gastrointestinal ailments are projected to stimulate fecal microbiota transplantation (FMT) market expansion in the future. These conditions encompass disorders of various parts of the gastrointestinal tract, including the esophagus, stomach, small intestine, large intestine (colon), rectum*, and anus. The surge in such illnesses can be attributed to intensified stress levels, inactive…
Fecal Incontinence Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Fecal Incontinence Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The fecal incontinence market is expanding due to the rising prevalence of conditions such as obesity, aging populations, and neurological disorders that contribute to this…
Global Fecal Immunochemical Diagnostic Test (FIT) Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Fecal Immunochemical Diagnostic Test (FIT) Market- (Product: Kits & Reagents, Analyzers, and Others), By End-user (Hospitals & Diagnostics Laboratories, Specialty Clinics, Home Care Settings and Research Institutes)) By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Fecal Immunochemical Diagnostic Test (FIT) Market is valued…
